The chemical class termed API5 inhibitors encompasses a diverse group of small molecules and compounds that have been systematically developed or fortuitously identified to selectively modulate the intricate interactions and regulatory functions associated with the Apoptosis Inhibitor 5 (API5) protein. API5 is known to exert its influence over fundamental cellular processes related to cell survival and apoptosis resistance. Inhibitors belonging to this class exhibit distinct structural attributes that confer upon them the ability to disrupt specific molecular interactions, signaling pathways, or binding interfaces involving API5. These compounds often possess unique chemical scaffolds and molecular features that enable them to perturb the delicate balance maintained by API5 in governing cellular fate decisions.
API5 inhibitors are characterized by their intricate and multifaceted mechanisms of action, which enable them to interfere with the nuanced network of interactions that API5 engages in. By targeting critical domains or interfaces within the API5 protein, these inhibitors hold the potential to abrogate or attenuate API5-mediated anti-apoptotic signals, potentially influencing cellular responses to apoptotic stimuli. The exploration of API5 inhibitors is an evolving area of research aimed at unraveling the intricate web of molecular events orchestrated by API5 and its involvement in cellular survival strategies. These compounds, with their unique chemical profiles, serve as invaluable tools for researchers seeking to decipher the molecular intricacies underlying API5's modulatory role in cell survival. Through rigorous experimentation and comprehensive investigations, researchers endeavor to uncover the precise mechanisms through which these inhibitors disrupt API5-mediated interactions, alter subcellular localization, or affect downstream signaling cascades.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressive drug that has been investigated for its potential inhibitory effects on APIIt has been suggested to interfere with the anti-apoptotic functions of API5. | ||||||
Xanthohumol from hop (Humulus lupulus) | 6754-58-1 | sc-301982 | 5 mg | $361.00 | 1 | |
Xanthohumol is a natural compound found in hops and beer. It has been studied for its potential anti-cancer properties and its ability to inhibit API5 expression, leading to enhanced apoptosis in cancer cells. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin is a flavonoid compound found in various plants. It has been investigated for its potential to inhibit API5 expression and interfere with its anti-apoptotic functions. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin is a flavonoid found in many fruits and vegetables. It has been explored for its potential to inhibit API5 expression and influence its anti-apoptotic activity. | ||||||
Celastramycin A | 491600-94-3 | sc-293989 sc-293989A | 1 mg 5 mg | $203.00 $906.00 | ||
Celastramycin A is a natural compound isolated from a marine fungus. It has been reported to inhibit API5 expression and sensitize cancer cells to apoptosis-inducing agents. | ||||||
API-1 | 36707-00-3 | sc-361106 | 10 mg | $275.00 | ||
API-1 is a compound that was designed to target the interaction between API5 and Hsp70. It has been suggested to disrupt this interaction, leading to enhanced apoptosis in cancer cells. | ||||||